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Abstract 
Review on t(X;11)(q28;p15), with data on the genes 
involved 
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Clinics and pathology 
Disease 
Therapy-related acute myeloid leukemia ( M4 
AML) 
Epidemiology 
Only one case to date: a 73-year-old female patient. 
Cytogenetics 
Cytogenetics morphological 
It is a semi-cryptic translocation, not visible with 
conventional cytogenetics alone and identified as a 
partner in the translocation after FISH technique 
with the NUP98 probe and the telomeric probe 
RP11-479B17 in the first reported case (Romana et 
al, 2006). 
Additional anomalies 
The patient showed a complex karyotype with a 
t(5;12)(q11;p13) as the only one chromosomal 
aberration observed in the stemline and a der(11) 
chromosome in two sidelines. (Romana et al, 2006). 
Genes involved and 
proteins 




HMGB3 encodes a member of a family of proteins 
containing one or more high mobility group (HMG) 
DNA-binding motifs. The protein plays an important 
role in maintaining stem cell populations, and may 
be aberrantly expressed in tumor cells. 




NUP98 belongs to the nucleoporin gene family and 
encodes a 186 kDa precursor protein that undergoes 
autoproteolytic cleavage to produce a 98 kDa 
nucleoporin and 96 kDa nucleoporin.  The 98 kDa 
nucleoporin contains a Gly-Leu-Phe-Gly (GLGF) 
repeat domain and participates in many cellular 
processes including nuclear import/export, mitotic 
progression, and regulation of gene expression. The 
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5' NUP98 - 3' HMGB3 
Description 
Nucleotide sequence analyses revealed an in-frame 
fusion of the exon 11 of NUP98 to the exon 2 of 
HMGB3. No reciprocal HMGB3-NUP98 transcript 
could be detected (Petit et al, 2010). 
Fusion protein 
 
Schematic representation of the NUP98/HMGB3 chimeric transcript, the native and chimeric proteins, showing 
the Gly-Leu-Phe-Gly (GLFG) repeats and RNA binding domain of NUP98 and the two high mobility group 
(HMG) boxes of HMGB3. 
Description 
The NUP98-HMGB3 protein is composed of the 
first 422 amino acids of NUP98 fused to the entire 
HMGB3 coding sequence (Petit et al, 2010). 
Oncogenesis 
The NUP98-fusion proteins induce leukemic 
transformation through the upregulation of HOXA 
genes and the Hox cofactor MEIS1. However, in 
mouse model, it has been shown the 
NUP98/HMGB3-expressing blasts upregulate 
HOXA9 only weakly and retain wild-type levels of 
MEIS1. Evidently, the transformation mediated by 
the NUP98/HMGB3 fusion does not involve 
deregulated activity of the canonical HOXA - 
MEIS1 pathway. The ectopic expression of 
HMGB3, as a result of the fusion with NUP98, can 
bypass the requirement of a concomitant HOXA9 
and MEIS1 misregulation in human malignancy. It 
seems that the several transformation pathways 
might be involved in the leukemogenic properties of 
NUP98 fusions. NUP98/HMGB3 is the first 
example of a NUP98 leukemogenic fusion whose 
expression is not associated with a strong HOXA and 
concomitant MEIS1 expression (Petit et al, 2010). 
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